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Abstract
This work aimed to establish the lineage of cells similar to the interstitial cells of Cajal (ICC), the arterial 
ICC-like (AIL) cells, which have recently been described in resistance arteries, and to study their location in the
artery wall. Segments of guinea-pig mesenteric arteries and single AIL cells freshly isolated from them were used.
Confocal imaging of immunostained cells or segments and electron microscopy of artery segments were used to
test for the presence and cellular localization of selected markers, and to localize AIL cells in intact artery segments.
AIL cells were negative for PGP9.5, a neural marker, and for von Willebrand factor (vWF), an endothelial cell
marker. They were positive for smooth muscle -actin and smooth muscle myosin heavy chain (SM-MHC), but
expressed only a small amount of smoothelin, a marker of contractile smooth muscle cells (SMC), and of myosin
light chain kinase (MLCK), a critical enzyme in the regulation of smooth muscle contraction. Cell isolation in the
presence of latrunculin B, an actin polymerization inhibitor, did not cause the disappearance of AIL cells from
cell suspension. The fluorescence of basal lamina protein collagen IV was comparable between the AIL cells
and the vascular SMCs and the fluorescence of laminin was higher in AIL cells compared to vascular SMCs.
Moreover, cells with thin processes were found in the tunica media of small resistance arteries using transmis-
sion electron microscopy. The results suggest that AIL cells are immature or phenotypically modulated vascular
SMCs constitutively present in resistance arteries.
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Introduction
The vascular smooth muscle cell (VSMC) is regarded
as a multifunctional mesenchymal cell [1]. Two princi-
pal phenotypes of VSMC were postulated historically:
‘contractile’ and ‘synthetic’ [2]. The more recent data
suggest that a continuum of cell phenotypes ranging
from immature/synthetic to contractile is a more
accurate representation of the VSMC differentiation
process and the phenotypic heterogeneity resulting
from it [3–6]. There are new data which also point
towards heterogeneous populations of VSMC coex-
isting in the vascular wall [6–8].
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The smooth muscle cell (SMC) expresses a set of
proteins, some of which are restricted to and unique
for the SMC lineage. Some proteins of this group,
such as smooth muscle -actin, appear early in the
SMC differentiation process, while the expression of
others, such as SM-MHC, calponin and smoothelin
starts at later stages [4,9]. This temporal pattern of
expression makes the individual proteins or their
combinations useful as markers of the particular
developmental stage of SMC.
Cells with irregular bodies and numerous thin long
processes, morphologically similar to the Interstitial
Cells of Cajal (ICCs), have recently been described
in the vasculature [10–12] and elsewhere outside the
gastrointestinal tract [13–20]. The cells found in por-
tal vein were positive for c-kit [10], a marker of ICCs,
and spontaneously produced rhythmical calcium
transients coupled to membrane depolarisations
[21], thus potentially acting as pacemakers in this tis-
sue. However, the cells found in resistance arteries,
the arterial ICC-like (AIL) cells, were c-kit negative
and were not observed to produce depolarizing cur-
rents spontaneously [11]. It was therefore of interest
to investigate the cell lineage to which AIL cells
belong and where they are localized in the arteries,
as a step towards elucidating their role. A preliminary




Experiments were carried out on single cells isolated from
the 1st to 7th order branches of guinea pig mesenteric artery
or on segments of these arteries. Dunkin-Hartley guinea-
pigs of either sex weighing 200–850 g were sacrificed by
cervical dislocation followed by exsanguination, in accor-
dance with the UK Animals (Scientific Procedures) Act 1986
(Schedule 1). Single cells were obtained by enzymic disso-
ciation [11] and stored at 4°C in physiological saline solution
(PSS, composition in mM:NaCl 120, KCl 6, glucose 12, HEPES
10, MgCl2 1.2, CaCl2 1.0, pH set to 7.4 with NaOH) until use.
Confocal microscopy
The cells were imaged using a Zeiss LSM 510 or a Nikon
C1 laser scanning confocal microscope. The excitation
beam was produced by an argon (488 nm) or a helium/neon
laser (543 or 633 nm), and delivered to the specimen via a
Zeiss Apochromat 63 oil immersion objective (numerical
aperture 1.4) or a Nikon CFI Fluor 60W objective (numer-
ical aperture 1.0). Emitted fluorescence was captured using
either Carl Zeiss LSM 510 or Nikon EZ-C1 software. When
the cells were scanned in three dimensions, z-slices were
0.1 µm apart.
Transmission electron microscopy
Vessel segments were isolated and placed in PSS contain-
ing 100 µM nicardipine for 3 hrs, to ensure maximal relax-
ation. The procedure for their preparation was the same as
previously described [11]. The preparations were viewed
with a Hitachi 7100 transmission electron microscope at 
75 kV and digital images recorded with a Gatan column-
mounted CCD camera.
Immunocytochemistry
Except for smooth muscle -actin labelling, in which case
methanol was used, and laminin and collagen IV labelling
where live cells were used, single cells or vessel segments
were fixed by 4% paraformaldehyde solution in PSS for 
10 or 30 min, respectively, washed with PSS and incubated
with PSS containing bovine serum albumin (BSA) and Triton
X-100. They were then incubated with primary antibodies in
PSS containing BSA overnight at 4°C, washed, and incu-
bated for 2 hrs with secondary antibodies conjugated with
fluorescent probes. After removing the unbound secondary
antibodies by washing with PSS, the preparations were
imaged using the laser scanning confocal microscope.
Antibodies used:
– PGP9.5: mouse monoclonal (clone 13C4, dilution 1:200,
final concentration 1.5 µg/ml);
– vWF: rabbit polyclonal (1:5000, 2.2 µg/ml);
– smooth muscle -actin: mouse monoclonal (1A4, 1:800,
5.6 µg/ml);
– SM-MHC: mouse monoclonal (HSM-V, 1:200, 50 µg/ml);
– smoothelin: mouse monoclonal (R4A, 1:50, unknown);
– MLCK: mouse monoclonal (K36, 1:10,000, 2.1 µg/ml),
visualised with Alexa Fluor 488-conjugated chicken anti-
mouse antibodies;
– laminin: rabbit polyclonal (1:200, 3 µg/ml);
– collagen IV: rabbit polyclonal (1:300, 3.3 µg/ml);
Unless specified otherwise, the preparations labelled with
mouse primary antibodies were visualized with Alexa Fluor
633-conjugated goat anti-mouse antibodies, and the ones
labelled with rabbit polyclonal antibodies with Alexa Fluor
488-conjugated chicken anti-rabbit antibodies. All the sec-
ondary fluorescent antibodies were used at dilution 1:500 
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(4 µg/ml). F-actin was stained with BODIPY 558/568 phal-
loidin (5 U/ml, 20 min). Nuclei were stained with SYTO 40
(500 nM, 15 min). PSS contained penicillin (20 U/ml) and
streptomycin (20 µg/ml) at all times during immunocyto-
chemical experiments.
Chemicals
BSA, Dulbecco’s Modified Eagle’s Medium (D-MEM),
paraformaldehyde, methanol, Triton X-100 and the antibod-
ies against smooth muscle -actin, SM-MHC and MLCK
were purchased from Sigma. Antibodies against smoothelin
were from Monosan (the Netherlands) and the ones against
PGP9.5, vWF, laminin and collagen IV were bought from
Abcam (UK). BODIPY 558/568 phalloidin and all the sec-
ondary antibodies conjugated with fluorescent dyes were
bought from Invitrogen (Molecular Probes). BODIPY
558/568 phalloidin was dissolved in methanol, all the other
substances in de-ionised water.
Analysis of data
Raw confocal imaging data were processed and analyzed
using Zeiss LSM 510 or Nikon EZ-C1 software. An image
cutting horizontally through approximately the middle of the
cell was selected out of a z-stack of images. Such an image
was used to calculate the average pixel fluorescence (APF)
as a quantification of the cell’s fluorescence signal intensity
and compare it between the cells. It was calculated using
the formula:
APF = (intensity units (I.U.)/pixel),
where pi is the intensity of a pixel within the confocal plane of
the cell (can be zero) and n(p) is the total number of pixels of
the plane.This number was calculated by delineating the con-
tour of the cell based on either its fluorescence or, in cases
when fluorescence was weak or absent, on transmitted light
image taken simultaneously with the fluorescence image,
and counting the number of pixels (using software) in such a
region.The compared APF was then expressed as a percent-
age of control APF. Statistical evaluation was carried out and
graphs constructed using MicroCal Origin software and final
images were produced using CorelDraw 10 software suite.
Statistics
Data are expressed as mean values ± s.e.m. for the number
of cells (n) analysed. Statistical significance was calculated
using Student’s t-test for paired observations unless other-
wise indicated and the differences where P < 0.05 were
considered significant.
Results
Neural and endothelial cell markers
A typical AIL cell is shown in Figure 4A.To test whether
the AIL cells are of neural or endothelial origin, single
cells adhering to coverslips were immunostained for
PGP9.5 (C-terminal ubiquitin hydroxylase), a neural
marker [23] or for vWF, a marker of endothelial cells,
respectively. The AIL cells did not show positive stain-
ing for either of the markers (Fig. 1A and B). In seg-
ments of small mesenteric arteries which acted as pos-
itive controls, PGP9.5 labelling was intense in fibres in
the adventitial layer, although five times lower laser
intensity than in the experiment with single cells was
used (Fig. 1C). The vWF antibodies labelled granule-
like bodies at the level of nuclei in the endothelial cells
(Fig. 1D), but not in the smooth muscle layer (not
shown). Omitting the primary antibodies resulted in a
virtual loss of fluorescence (Fig. 1D, inset).
Smooth muscle cell markers
All the experiments involving SMC markers were car-
ried out by imaging pairs of closely adjacent AIL cells
and VSMCs in the same microscope field, to allow for
direct comparison between their fluorescent signals.
Our previous work has shown the presence of
actin in AIL cells [11], but this was done using a fluo-
rescent derivative of phalloidin, which does not dis-
criminate between the actin isoforms. In this work we
tested for the presence of smooth muscle a-actin
(SMaA), a smooth muscle specific isoform of actin
which is expressed in the early stages of the VSMC
development and regarded as a marker of cells with
VSMC commitment [4]. Both AIL cells and VSMCs
stained positive for SMaA. The fluorescent signal
originated from all of the cytoplasm except the cen-
tral part occupied by the nucleus (Fig. 2B) and, in
case of AIL cells, also from filopodia. The signal
intensity in AIL cells was significantly lower than that
in VSMCs (Fig. 2C).
SM-MHC is regarded as a more selective VSMC
marker than SMA, as it starts being expressed later
in the VSMC development, at the stage of immature
VSMCs [4]. Its presence in AIL cells and VSMCs has
been demonstrated earlier [11]. In this work we com-
pared the SM-MHC signal intensity between AIL
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cells (Fig. 2D). The SM-MHC fluorescence signal
from the AIL cells was not statistically different from
that of VSMCs (Fig. 2F). Weak signal was also
detected from the filopodia (Fig. 2E, arrows).
Smoothelin is at present considered to be the
most selective marker of contractile VSMCs [4], as it
is not expressed in immature forms of VSMC.
Imaging of pairs of cells (an AIL cell and a VSMC)
has shown smoothelin distribution throughout the
cytoplasm of VSMCs, except for the central part,
occupied by the nucleus, but significantly less of it (in
some cases virtual absence) in the AIL cells (Fig. 3B
and C). This result suggested that AIL cells are
immature or phenotypically modulated VSMCs.
MLCK is a critical enzyme in the regulation of
smooth muscle contraction. As AIL cells were
shown to be non-contractile [11], but expressing
both actin and myosin, it was of interest to establish
Fig. 1 Fluorescent staining for PGP9.5 and vWF. (A) A combined image of transmitted light (shades of grey) and
PGP9.5 fluorescence (red) of VSMCs and AIL cells (arrows) obtained by confocal microscopy. Neither AIL cells nor
VSMCs stained positive for PGP9.5 (n = 24 cells). (B) A combined image of transmitted light (shades of grey) and vWF
fluorescence (green) of an AIL cell, showing only weak non-specific staining (n = 6). Inset: Same cell stained with
BODIPY 558/568 phalloidin (yellow) revealed the presence of otherwise faintly visible filopodia, confirming the identi-
ty of an AIL cell. (C) Same as in (A), but a segment of mesenteric artery was used, showing the presence of nerve
fibers (positive control, n = 5). (D) A fluorescent image of an endothelial layer in mesenteric artery segment immunos-
tained for vWF and stained with SYTO 40 for nucleic acids. Nuclei of endothelial cells can be seen in blue. Green colour
shows vWF staining of granular appearance, due to its storage in the Weibel-Palade bodies of endothelial cells 
(n = 4). Inset: As for the main panel, but the primary antibodies to vWF were omitted.
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their relative level of MLCK expression. Similarly to
cellular distribution of SMA, SM-MHC and
smoothelin, our experiments show a cytoplasm-
wide presence of MLCK (Fig. 3E). The intensity of
MLCK fluorescent signal was significantly lower in
AIL cells than in VSMCs (Fig. 3F), which is in
accordance with their inability to contract and cor-
roborates the view that they are of immature
VSMC phenotype.
Control experiments were carried out for each
marker. Incubation of cells with primary antibodies
alone did not produce any fluorescence, and the
incubation with secondary antibodies alone resulted
in average fluorescence signals ranging from less
than 0.1–8.7% of the original intensity (see legends
to Fig. 2 and 3 for details).
Are AIL cells constitutively present or
an artefact of cell isolation?
The finding that AIL cells are closely related to the
contractile phenotype of VSMC gave rise to a ques-
tion whether they are indeed constitutively present in
intact arteries, or are just an artefact resulting from
phenotypic modulation of VSMCs during cell isola-
tion, due to tissue injury. Several experiments were
carried out to address this issue.
To establish whether AIL cells originate from
arteries of a specific size/diameter or are found
throughout the mesenteric artery tree, a parallel dis-
sociation of arteries pooled into six groups accord-
ing to their branch order (6th group contained arter-
ies from branches of 6th or higher order) was carried
Fig. 2 Fluorescent staining for SMA and SM-MHC. (A) Transmitted light image of an AIL cell and two VSMCs and 
(B) an image of SMA fluorescence in the same cells, obtained by confocal microscopy. (C) SMA fluorescence of AIL
cells was 55.5 ± 10.2% of that in VSMCs (n = 6 cell pairs, P = 0.0074, significantly different). Omitting primary antibodies 
(n = 9) produced in average 1.8% of the original fluorescence intensity (n = 6; not shown). (D) and (E) As for (A) and (B),
but staining for SM-MHC is shown. (F) SM-MHC fluorescence of AIL cells was 98.9 ± 5.8% of that in VSMCs (n = 7 cell
pairs, P = 0.852). Omitting primary antibodies (n = 10) produced an average of less than 0.1% of the original fluorescence
intensity (n = 7; not shown). Arrows point to filopodia of AIL cells. In both cases, fluorescence was found throughout the
cytoplasm of VSMCs and AIL cells, except for the centre, occupied by nucleus (arrowheads). * Statistically significant.
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out. AIL cells were observed in arteries of each
branch order (not shown).
If some VSMCs started to modulate their pheno-
type and grow filopodia after tissue injury, thus giving
rise to AIL cells, then blocking actin elongation would
prevent this process and result in the absence of AIL
cells in cell suspensions. When 20 µM latrunculin B,
an inhibitor of actin polymerization (Kd=~200 nM [24]),
was present immediately after tissue excision and
throughout the tissue dissociation, AIL cells were still
found in suspension (Fig. 4B). However, the number of
filopodia per cell (Fig. 4C) and their average length
(Fig. 4D) were significantly smaller. Similarly, cell dis-
sociation in D-MEM (free calcium concentration
buffered to 50 µM) also resulted in AIL cells having
fewer and shorter filopodia (Fig. 4C and D).
Isolation of single cells from tissue involves
destroying the extracellular matrix embedding the
cells. Enzymes like collagenase or protease, used
in our experiments, can thus degrade the basal lam-
ina of VSMCs. The protein components of basal
lamina, laminin and collagen IV, exert a contractile
phenotype-promoting influence on VSMCs [25, 26]
and their removal could induce a phenotypic modu-
lation into a synthetic/immature phenotype. If
excessive basal lamina shedding of VSMCs indeed
Fig. 3 Fluorescent staining for smoothelin and MLCK. (A) Transmitted light image of an AIL cell and a VSMC and (B) an
image of smoothelin fluorescence in the same cells, obtained by confocal microscopy. (C) Smoothelin fluorescence of AIL
cells was 21.4 ± 8.7% of that in VSMCs (n = 10 cell pairs from three animals, P = 0.00001, statistically significant).
Omitting primary antibodies (n = 29 cells from five animals) produced an average of 2.6% of the original fluorescence
intensity (n = 10; not shown). (D) Transmitted light image of an AIL cell and a VSMC combined with the image of BOD-
IPY phalloidin fluorescence of the bottom plane (in white; to enhance the visibility of filopodia). (E) As for (B), but stain-
ing for MLCK is shown. (F) MLCK fluorescence of AIL cells was 32.1 ± 6.6% of that in VSMCs (n = 9 cell pairs, P =
0.00001, statistically significant). Omitting primary antibodies (n = 7) produced an average of 8.7% of the original fluores-
cence intensity (n = 9; not shown). The fluorescence of both markers was localized throughout the cytoplasm of VSMCs
and AIL cells, except for the nucleus. Arrows point to filopodia of AIL cells. * Statistically significant.
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makes them convert to AIL cells, then the layer of
laminin and/or collagen IV on the surface of AIL
cells is likely to be sparser than on VSMCs. To test
this hypothesis, live single cells (i.e. fixation and
permeabilization steps were omitted) were
immunostained for these proteins and their signal
intensities were compared between AIL cells and
VSMCs. The surface of AIL cells and VSMCs
stained positive for both laminin (Fig. 4E) and colla-
gen IV (Fig. 4F). There was no significant difference
between the fluorescent signal intensities of colla-
gen IV, but the laminin signal was significantly
stronger in AIL cells than in VSMCs (Fig. 4G). In
control experiments, omitting primary antibodies
resulted in virtual loss of fluorescence. The cells did
not stain for fibronectin, collagen I, elastin or -actin
Fig. 4 (A) Transmitted light image of an
AIL cell isolated using the usual proce-
dure. (B) Transmitted light image of three
AIL cells isolated in the presence of 20
µM latrunculin B. (C) The average number
of filopodia per cell was decreased from
9.9 ± 1.0 per cell, n = 25 in control (Ctrl)
to 6.4 ± 0.5 per cell, n = 39 in latrunculin
B (Lat B), P = 0.0006, significantly differ-
ent. Cell isolation in Dulbecco’s Modified
Eagle’s Medium (D-MEM) also decreased
it from 14.3 ± 1.8 per cell, n = 10 in 
control to 3.8 ± 0.4 per cell, n = 14, 
P = 0.000002, significantly different. (D)
The average length of filopodia was
decreased from 14.4 ± 0.8 µm, n = 99 in
control to 8.2 ± 0.8 µm, n = 55 in latrun-
culin B, P = 0.000003, significantly differ-
ent, and from 16.0 ± 0.7 µm, n = 143 
in control to 10.3 ± 0.7 µm in D-MEM, 
n = 53, P = 0.00003, significantly different.
(E) Image of laminin fluorescence in an
AIL cell and two VSMCs obtained by con-
focal microscopy. Inset shows the same
cells in transmitted light. Arrows point to
some of the filopodia. (F) Same as in (E),
but staining for collagen IV is shown. (G)
Laminin fluorescence of AIL cells was
131.9 ± 9.6% of that in VSMCs (n = 8 cell
pairs, P = 0.013, significantly different)
and collagen IV fluorescence was 113.3 ±
12.1% of that in VSMCs (n = 9 cell pairs,
P = 0.305). Omitting primary antibodies
produced virtually no fluorescence in both
cases (n = 13 and n = 12, respectively;
not shown). * Statistically significant dif-
ference to control.
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(not shown), ruling out non-specific adherence of
antibodies to the cell surface.
AIL cells in intact resistance arteries
At present there is no selective marker of AIL cells
able to discriminate clearly between them and the
VSMCs, which precludes their direct visualization and
localization in intact arteries. For this reason, transmis-
sion electron microscopy (TEM) was used to check for
the presence and localization of cells with the mor-
phology of AIL cells in artery segments. In contrast to
our previous work [11], segments of mesenteric artery
(1st to 7th order branches) were maximally relaxed by
3 hr exposure to 100 µM nicardipine.The TEM images
showed the presence of cells with thin processes scat-
tered in the media (Fig. 5). The processes were in
close apposition to surrounding cells, however their
exact length and contacts with other cells could not be
established from a single tissue section.The thickness
of these processes was comparable to that of filopodia
seen in isolated AIL cells, but their number per cell
appeared smaller.
Discussion
The results of the present work suggest that AIL cells
are closely related to the contractile VSMCs and are
constitutively present in the resistance arteries of a
mammalian species.
Being isolated from arteries, AIL cells could be
one of a number of different cell types: neural or
endothelial cells, fibroblasts, dendritic cells, myofi-
broblasts, pericytes, ICCs or immature VSMCs. The
results of the present work show that the AIL cells
are unlikely to be neural or endothelial cells, as they
did not express the markers of these cell types. The
results of our previous work [11] have shown that
they are c-kit negative and thus unlikely to be the
ICCs in the strict sense of word. As they express
SMA, they are not fibroblasts, and the presence of
SM-MHC strongly suggests they are not dendritic
cells either [27]. The pericytes are only found in pre-
capillary arterioles, capillaries and post-capillary
venules. The fact that AIL cells were isolated from
each order of mesenteric artery branches (external
diameter 120–500 µm [11]) makes unlikely the pos-
sibility that AIL cells are pericytes.
Fig. 5 Cells with thin processes in
intact mesenteric arteries.
Transmission electron micro-
graphs of an oblique section
through mesenteric artery.
Rectangles in (A) and (C) delineat-
ed by dashed line indicate areas
which are shown enlarged in (B)
and (D), respectively. Adv - adven-
titia, ec – endothelial cell, iel – inter-
nal elastic lamina, n – nucleus.
Arrows indicate processes. The
cells with thin processes can be
seen in the tunica media.
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The presence of SMA and SM-MHC in AIL cells
suggests that they belong to the smooth muscle lin-
eage and are differentiated to at least the level of
myofibroblasts. Myofibroblasts are characterized by
the presence of fibronectin-rich fibronexuses on their
surface and a lack of basal lamina [28]. AIL cells
were positive for collagen IV and laminin and nega-
tive for fibronectin, which indicates the presence of
basal lamina and a lack of fibronexuses and strongly
suggests they are not myofibroblasts.
Smoothelin is a protein associated with the
cytoskeleton and found in contractile SMCs [29, 30].
It has been shown to be an indicator of SMC pheno-
type modulation [31]. In small muscular arteries (less
than 10 layers of SMCs), more than 95% of SMCs
express smoothelin [32]. The very weak or absent
smoothelin signal in AIL cells indicates that they are
not differentiated to the level of a contractile/mature
VSMC. This result and the observation that AIL cells
express significantly less MLCK than VSMCs offers
one explanation for our earlier observation that AIL
cells, despite expressing SMA and SM-MHC, are
unable to contract [11].
Cells identified as arterial ICCs have been
described in human aorta and carotid artery [33].
These cells were found along the border between
media and adventitia, where they were in direct con-
tact with nerve endings. They too were c-kit negative,
but a subset of them was positive for neurokinin 1
receptor (NK1R). Preliminary experiments with
immunocytochemical staining without the signal
amplification did not detect these receptors in AIL
cells from guinea-pig mesenteric arteries (unpub-
lished results). At present, there is insufficient data to
decide whether there is a relation between arterial
ICCs from human conduit arteries and AIL cells from
guinea-pig resistance arteries.
Upon enzymatic dissociation of the vessel or
injury, the inhibitory influence of the endothelium and
of the extracellular matrix on VSMCs is removed and
the contractile VSMCs can spontaneously modulate
their phenotype into a synthetic one after 3–7 days in
cell culture [34–36]. Therefore, the possibility existed
that the AIL cells do not occur in intact arteries, but
that the freshly isolated VSMCs rapidly modulate
their phenotype, turning into AIL cells.
However, several lines of evidence suggest this is
unlikely. Firstly, the TEM images of artery segments
have shown cells with processes in the tunica media
[11]. The thickness of the processes was comparable
to that of filopodia seen in isolated AIL cells. In this
work, the segments were maximally relaxed to mini-
mize squeezing and folding of cells, which, when
observed in tissue sections, can be mistaken for thin
processes, a distinguishing feature of AIL cells.
However, despite this intervention, cells with thin
processes were still observed in artery sections.
Secondly, if VSMCs were indeed modulating their
phenotype into AIL cells after the integrity of arteries
had been disrupted, it would not be possible to find
cells with thin processes in intact arteries, that is
before the integrity is disrupted. It was shown that the
elongation of filopodia in AIL cells was abolished by
latrunculin B, an actin polymerization inhibitor [11].
Continuous presence of supramaximal concentration
of latrunculin B during isolation would prevent the
development and elongation of filopodia and conse-
quently, no AIL cells would be observed in cell suspen-
sion. The most plausible explanation to our observa-
tion that AIL cells were present even in the single cell
suspension obtained in the presence of latrunculin B
is that cells with thin processes were already present
in intact arteries before isolation. As the experiments
with cell isolation in D-MEM suggest, one reason why
the cells in intact tissue have fewer and shorter
processes could be the inhibitory influence of an envi-
ronment rich in nutrients on the growth of filopodia.
Thirdly, if AIL cells were an artefact brought about
by shedding of basal lamina from VSMCs and their
subsequent phenotypic modulation into an imma-
ture/synthetic phenotype, then the laminin and colla-
gen IV content of AIL cells would be lower than that
of VSMCs. Quite the opposite, the experiments have
shown that the laminin signal was stronger in AIL
cells than in VSMCs and the collagen IV signal not
significantly different.
Lastly, smoothelin was all but absent from AIL
cells. The smoothelin mRNA levels have been report-
ed to fall sharply by 12 hrs from the removal of tissue,
but the protein itself remains present in the cells for up
to 5 days [29]. It is therefore unlikely that the VSMCs
would be able to down-regulate their smoothelin con-
tent within less than 6–7 hrs, which was the longest
time from tissue removal to cell fixing.
These observations, together with the immediate
presence of AIL cells after isolation and the observed
differences in actin cytoskeleton organization between
the AIL cells and the VSMCs [11, 37] argue in favour
of a resident population of AIL cells within the tunica
media. Differences in expression pattern of markers
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giving rise to heterogeneous subpopulations of
VSMCs have been observed both in healthy [38] and
in atherosclerotic vessels [39], although such cells
were observed in tissue sections and no striking mor-
phological differences between them, like the pres-
ence of filopodia, were reported. Recent data [40],
showing evidence that in atherosclerosis the VSMCs
originate from the local vessel wall and not from pro-
genitor cells in the circulation, further support the idea
of resident immature VSMCs. However, the question
of VSMC origin is a matter of controversy, as other
works suggest existence of a population of circulating,
c-kit positive VSMC progenitors [41, 42]. ICC-like cells
have also been identified in the sections of human and
rat atria [43] and ventricles [44] by electron and light
microscopy, suggesting the presence of ICC-like cells
throughout the cardiovascular system.
Thus, the results suggest that AIL cells are an
immature (also referred to as synthetic or epithelioid)
phenotype of VSMC, constitutively present in the
media of resistance arteries.
We hypothesise that they belong to a VSMC contin-
uum where, on the one extreme lie the contractile,
mature VSMCs and on the other extreme the pace-
making, specialized, c-kit positive ICCs (the transition
of ICCs into SMCs in the absence of c-kit signalling has
been demonstrated in the gastrointestinal tissue [45]).
The possibility that the constitutive presence of AIL
cells in the vessel wall plays role in vascular remodel-
ling is intriguing, but their migratory and proliferative
potential would need to be investigated to address this
hypothesis. Together with the cardiac ICC-like cells,
which have also been suggested to be uncommitted
progenitor cells [43, 44], AIL cells as a possible inter-
mediate VSMC phenotype might become a promising,
albeit sparse target for therapeutic interventions. There
is insufficient data at present to conclusively establish
whether ICC-like cells in arteries are able to act as
pacemakers; consequently, their role in vasomotion
cannot be ruled out. In practical terms, the constitutive
presence of immature VSMCs provides an opportunity
to study them on a single cell level in a situation that is
as close as experimentally possible to the normal 
physiological environment.
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